Oral Communications I: Cardiovascular & Metabolic Pharmacology
Tracks
MC 2 Hall
| Tuesday, June 25, 2024 |
| 4:15 PM - 6:15 PM |
| MC2 Hall |
Speaker
Dr. Yandi Wu
City University Of Hong Kong
OC01. E2F Transcription Factor 2 (E2F2) Facilitates Atherosclerosis Through CCAAT Enhancer Binding Protein β Mediated Endothelial Cell Inflammation
Ms. Janina Mettner
Department For Vascular Dysfunction
OC02. Cyst(e)ine import and catabolism preserve endothelial chromatin accessibility and promote vessel growth
Dr. Panagiotis Efentakis
Postdoctoral Researcher
National and Kapodistrian University of Athens
OC03. Investigating the cardioprotective potential of novel Sirtuin agonists. Sirtuin 5 emerges as a new target in mitigating myocardial ischemia-reperfusion injury
Prof. Gonen Özşarlak-Sözer
Assoc. Prof.
Ege University Faculty of Pharmacy
OC04. Effect of SGLT2i on heart tissue in diabetic rats: SIRT1 connection
Ms. Georgia Kakafoni
PHD student
University Of Patras
OC05. The functional interaction of Apolipoprotein A2 with the metabolic system of apolipoprotein E -rich- lipoproteins in the regulation of the lipid profile
Ms. Eleonora Aimaretti
Phd Student
University of Turin
OC06. Potential repurposing of the SYK inhibitor Fostamatinib in a diet-induced model of insulin resistance: an in vivo study
Ms. Elisa Porchietto
Phd Student
University Of Camerino
OC07. Pharmacological inhibition of cyclin-dependent kinase 9 (CDK9) ameliorates metabolic abnormalities evoked by chronic consumption of hypercaloric diet in mice
Dr. Charikleia Ntenti
Researcher
freiburg universitatsklinikum
OC08. FKBP5 rs4713916 could serve as a genetic predictor of interindividual different response to inhaled corticosteroids in patients with chronic obstructive pulmonary disease
Chair
Mariarosaria Bucci
Full Professor Of Pharmacology
University Of Naples -federico Ii-
Achilleas Gravanis
Professor & Chair
Medical School University Of Crete
